About Coloplast
Coloplast is a publicly listed company based in Humlebaek (Denmark) founded in 1957. Medical devices for ostomy, urology, and wound care are manufactured. It operates on a Direct-to-Consumer (D2C) and Professional Services model. The company has 16,640 employees. Coloplast has completed 7 acquisitions, including Atos Medical, Comfort Medical and IncoCare. Its chief executive, as recorded, is Kristian Villumsen. Its website coloplast.com draws about 155 thousand monthly visits. Its Indian entity Coloplast (India) Private Limited reported revenue of ₹134 Cr. Coloplast offers products and services including Ostomy Care Products, Continence Care Products, Interventional Urology Products, Bowel Care Products, and Advanced Wound Care Products. Its focus areas include Medical Devices and Intimate Healthcare Solutions.
Company details
Intimate healthcare solutions are developed by Coloplast to support people with specific medical needs. Focus is placed on areas such as ostomy care, continence care, interventional urology, bowel care, advanced wound care, and voice and respiratory care. Products and services are tailored to improve quality of life for users across over 100 countries. Support is also extended to healthcare professionals through education and tools to enhance patient care. Innovation and empathy are prioritized to address the unique challenges faced by individuals with intimate healthcare conditions.
- Headquarters Humlebaek, Denmark
- Employees 16,640
- Stage Public
- SectorsHealthcare
- Website category Health
- Phone•••• ••••
- Website coloplast.com
- Social LinkedIn Facebook Instagram YouTube
- Legal Name Coloplast A/S Class B
- Indian entity revenue₹134 Cr
FY 2025 · -6% YoY
- Indian entity net profit₹6.06 Cr
FY 2025 · 5% margin
- Indian entity EBITDA₹8.67 Cr
FY 2025 · 6% margin
- Employee Count16,640
- Investments & AcquisitionsAtos Medical
& 6 more
Associated legal entities of Coloplast
Coloplast operates through Coloplast (India) Private Limited (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2025) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Coloplast (India) Private Limited CIN U24100DL2011PTC217304 | Active | 08 Apr 2011 | New Delhi, Delhi | ₹134 Cr | 198 | 5 | View details |
Products & Services of Coloplast
Coloplast offers a comprehensive portfolio of products and services, including Ostomy Care Products, Continence Care Products, Interventional Urology Products, Bowel Care Products, and Advanced Wound Care Products.
Ostomy bags and supports are provided for patients.
Intermittent catheters and devices are offered for continence.
Implants and surgical tools are supplied for urology.
Transanal irrigation systems are developed for bowel management.
Wound dressings and biologics are provided for healing.
Apps and channels of Coloplast
its YouTube channel Coloplast Bladder & Bowel has 86.8K subscribers and 30 videos.
Videos from Coloplast
The most watched videos on Coloplast's YouTube channel, Coloplast Bladder & Bowel (86.8K subscribers). Click a video to play it here.
More on Coloplast Bladder & Bowel.
Board of directors of Coloplast (India) Private Limited (Coloplast)
Coloplast (India) Private Limited is the primary company behind Coloplast. The board of Coloplast (India) Private Limited currently have 5 directors; the longest-serving is Henrik Deneke, appointed in 2014. 14 earlier directors have ceased.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Henrik Deneke DIN 06998231 | Director | 20 Oct 2014 | 12 yrs | Coloplast (India) Private Limited |
| Anton Malling Mikkelsen DIN 09806237 | Director | 29 Nov 2022 | 3 yrs 10 mo | Coloplast (India) Private Limited |
| Thomas Christian Bruhn DIN 10302136 | Director | 01 Sep 2023 | 3 yrs 1 mo | Coloplast (India) Private Limited |
| Bhaskar Azad DIN 10797936 | Additional Director | 07 Oct 2024 | 2 yrs | Coloplast (India) Private Limited |
| Sourabha Ramesh Nadipuram DIN 10867307 | Additional Director | 11 Dec 2024 | 1 yr 10 mo | Coloplast (India) Private Limited |
People of Coloplast
368 people are tracked at Coloplast (138 in leadership, 8 in board & advisors, 222 in team); the tracked headcount is 16,640.
| Name | Role | Group |
|---|---|---|
Kristian Villumsen | CEO | Leadership |
Caroline Vagner Rosenstand | VP, Corporate Development & Strategy | Leadership |
Lars Rasmussen | Chairman & Interim CEO | Leadership |
Kostyantyn Pivnenko | Head Of Sustainability Product Impact | Leadership |
Ida Munk Larsen | Head Of Leadership And Learning | Leadership |
Thomason Anders | Director Of Reporting Solutions And Finance Projects | Leadership |
Frederik Schou Løvendal | Head Of New Markets | Leadership |
Dorthe Rønnau | Executive Vice President, People & Culture | Leadership |
Maria Lacoppidan | Director Group Development & Strategy | Leadership |
Johan Mastrell | Senior Vice President Region UK & Ireland | Leadership |
Roland Doll | Integration Lead Germany, Director, Group Development & Strategy | Leadership |
Dan Oster | Director Of Product Development | Leadership |
Nadeem Younas | Finance Business Partner | Leadership |
Anders Lonning-Skovgaard | EVP & CFO | Leadership |
Sohail Assi | Emerging Markets & Asia Pacific Director | Leadership |
Maria Breitenstein | Personal Assistant To Executive Management (cfo) | Leadership |
Kurt Duff Ca | Head Of Finance And Business Support | Leadership |
Kathleen M. McCarthy | Senior Director, People And Culture, Interventional Urology | Leadership |
Fie Vensby | Senior People & Culture Director, Global Operations | Leadership |
Tanja Gourbo-Novik | Senior Director, People & Culture - Emerging Markets | Leadership |
348 more people are available in the full profile.
Complete people profiles for Coloplast
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
IPO & Listings of Coloplast
Coloplast is a publicly listed company on the OMXCOP with ticker symbol COLO_B in Denmark, operating in the Health technology sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
- IPO date23 Apr 2015
- Listed onBMV: 0QBON
- Listed entityColoplast A/S Class B
- Exchange sectorHealth technology
- ISINDK0060448595
- Share price459.90 DKK (+0.88% on the day) · 2026-10-14
- Market capitalisation102,577,797,755.00 DKK
- Price to earnings37.5
- EPS (diluted, trailing year)12.26 DKK
- Dividend yield5.04%
- Volume (last session)36,818
Financials of Coloplast
Figures of Coloplast (India) Private Limited, the primary company behind Coloplast, for FY 2025. Revenue was ₹134 Cr (-6% year on year). Net profit was ₹6.06 Cr (5% margin). EBITDA was ₹8.67 Cr (6% margin). Revenue has grown at a compounded annual rate of +16% over three years and +15% over five years.
- ₹134 CrRevenue · FY 2025 · -6% YoY
- ₹6.06 CrNet profit · 5% margin
- ₹8.67 CrEBITDA · 6% margin
- ₹75 LakhPaid-up capital
- 198Employees (provident fund records)
- +16%Revenue CAGR, 3 years
- +15%Revenue CAGR, 5 years
| Year | Revenue | Net income | EBITDA |
|---|---|---|---|
| 2025 | 27.87B DKK | 3.64B DKK | 8.93B DKK |
| 2024 | 27.03B DKK | 5.05B DKK | 8.70B DKK |
| 2023 | 24.50B DKK | 4.78B DKK | 7.86B DKK |
| 2022 | 22.58B DKK | 4.71B DKK | 7.77B DKK |
| 2021 | 19.43B DKK | 4.83B DKK | 7.06B DKK |
Balance sheet, profit and loss, cash flow and ratios of Coloplast (India) Private Limited are on its company page.
Detailed financial statements for Coloplast
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Coloplast
Coloplast has strategically engaged in corporate development activities, having acquired 7 companies. Notable acquisitions include Atos Medical, Comfort Medical and IncoCare.
| Company Name | Description | Domain | Location | Founded | Acquired | Amount |
|---|---|---|---|---|---|---|
Fish-skin acellular dermal matrix technology is provided for wound treatments. | kerecis.com | Isafjordur, Iceland | 2007 | Jul 2023 | •••• | |
Medical devices for laryngectomy, tracheostomy, and jaw rehabilitation are developed. | atosmedical.com | Malmo, Sweden | 1986 | Nov 2021 | $2.54B | |
Devices for personal and private medical conditions are manufactured. | 9cmed.com | Livermore, United States | 2014 | Nov 2020 | $145M | |
Stoma and continence care products and support services are provided. | incocare.de | Bogen, Germany | 1998 | Feb 2018 | •••• | |
Provider of a domain name for sale | lilial.fr | 2003 | Dec 2017 | $41.7M | ||
Home delivery of catheter and ostomy supplies is provided. | comfortmedical.com | Miami, United States | 2010 | Nov 2016 | $159.7M | |
Surgical meshes for treating women's urinary incontinence are developed. | mpathymedical.com | Raynham, United States | 2003 | Oct 2011 | $35.26M |
Complete acquisition details for Coloplast
Acquired stakes, deal sources and the complete acquisition history require an active premium plan.
- Acquired stakes
- Deal sources
- Complete history
- Exports
Verified entity values are shown only after access is granted.
Timeline of Coloplast
9 dated milestones of Coloplast across 66 years, from founding to its latest funding, stage changes and deals.
- Founded Coloplast is founded.
- Acquisition Acquires Mpathy Medical Devices.
- IPO Lists on the stock exchange (IPO).
- Acquisition Acquires Comfort Medical.
- Acquisition Acquires Lilial.
- Acquisition Acquires IncoCare.
- Acquisition Acquires Nine Continents Medical.
- Acquisition Acquires Atos Medical.
- Acquisition Acquires Kerecis.
Web traffic of Coloplast
The website of Coloplast (coloplast.com) receives about 155.3K visits a month and ranks #298,292 among all websites worldwide, #10,355 in Health.
- Monthly visits155.3K
▲ 21.9% vs previous month
- Unique visitors55.7K
per month
- Global rank#298,292
among all websites
- Category rank#10,355
Health · Health
- Bounce rate46%
- Pages per visit2.4
- Average visit56 sec
- DevicesDesktop 40% · Mobile 60%
Websites whose visitors overlap most with Coloplast. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| convatec.com | 100% | 258.8K | #193,008 | View details | |
| bostonscientific.com | 91% | 738.5K | #88,615 | View details | |
stlmedical.com | stlmedical.com | 82% | – | ||
| erex24.fr | 80% | View details | |||
| nu-hope.com | 79% | #5,185,277 | View details | ||
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
All 25 similar websites and full traffic analytics for Coloplast
The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.
- 25 similar websites
- Audience overlap
- Engagement analytics
- Traffic by brand
Verified entity values are shown only after access is granted.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Coloplast
Complete news archive for Coloplast
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Coloplast
Coloplast was founded in 1957.
Coloplast is headquartered in Humlebaek, Denmark.
Kristian Villumsen is the CEO of Coloplast, as recorded in our data.
Coloplast has 16,640 employees.
The primary company behind Coloplast, Coloplast (India) Private Limited, reported revenue of ₹134 Cr for FY 2025, down 6% year on year.
Intimate healthcare solutions are developed by Coloplast to support people with specific medical needs. Focus is placed on areas such as ostomy care, continence care, interventional urology, bowel care, advanced wound care, and voice and respiratory care. Products and services are tailored to improve quality of life for users across over 100 countries. Support is also extended to healthcare professionals through education and tools to enhance patient care. Innovation and empathy are prioritized to address the unique challenges faced by individuals with intimate healthcare conditions.
Coloplast offers Ostomy Care Products, Continence Care Products, Interventional Urology Products, Bowel Care Products, and Advanced Wound Care Products.
Yes, Coloplast is publicly traded on OMXCOP under the ticker symbol COLO_B.
Coloplast has made 7 acquisitions, including Atos Medical, Comfort Medical, and IncoCare.
Coloplast operates through Coloplast (India) Private Limited.
The legal entities of Coloplast currently have 5 directors, including Thomas Christian Bruhn, Anton Malling Mikkelsen, Bhaskar Azad and others.
The website of Coloplast receives about 155 thousand visits a month and ranks #298,292 among all websites worldwide.